Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00686647 · ClinicalTrials.gov registry record · NA
AngioSculpt® Coronary Bifurcation Study
A NA study of Coronary Artery Disease and Myocardial Ischemia, sponsored by AngioScore.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT00686647: Completed NA study of Coronary Artery Disease and Myocardial Ischemia, sponsored by AngioScore.
NCT00686647 is a NA study of Coronary Artery Disease and Myocardial Ischemia that has completed, run by AngioScore. The registered enrollment target is 93 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00686647, a NA study of Coronary Artery Disease and Myocardial Ischemia, has completed, sponsored by AngioScore.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.
Primary Outcome
Defined as less than or equal to 30% diameter stenosis in the main branch and less than or equal to 70% diameter stenosis in the side branch at the conclusion of the procedure (including adjunctive stenting) in the absence of in-hospital major adverse cardiac events (MACE) \[cardiac death, myocardial infarction (MI), or target lesion revascularization (TLR\]
Conditions Studied
Interventions
- DEVICE AngioSculpt® Scoring Balloon Catheter
- DEVICE AngioSculpt Scoring Balloon Catheter
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2008-04 |
| Est. Completion | 2011-01 |
| Phase | NA |
What the finished NCT00686647 record still lists
NCT00686647 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which AngioSculpt® Scoring Balloon Catheter is the first listed.
NCT00686647 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00686647 about?
NCT00686647 is a clinical study titled "AngioSculpt® Coronary Bifurcation Study". The purpose of this study is to evaluate a new angioplasty catheter, AngioSculpt® for the treatment of bifurcation lesions (blockages occurring at branch points) in coronary arteries.
What is the current status of trial NCT00686647?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2008-04. Estimated completion is 2011-01.
What conditions does trial NCT00686647 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Ischemia.
What interventions are being tested in trial NCT00686647?
The interventions under investigation include: AngioSculpt® Scoring Balloon Catheter (DEVICE), AngioSculpt Scoring Balloon Catheter (DEVICE).
Who is sponsoring clinical trial NCT00686647?
This trial is sponsored by AngioScore, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00686647 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00686647's enrollment target sits among peer trials
93 153rd of 219 higher than 67 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia